These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 20133980)

  • 21. Increased spontaneous apoptosis of CD4+CD25+ T cells in patients with active rheumatoid arthritis is reduced by infliximab.
    Toubi E; Kessel A; Mahmudov Z; Hallas K; Rozenbaum M; Rosner I
    Ann N Y Acad Sci; 2005 Jun; 1051():506-14. PubMed ID: 16126991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increase of regulatory T cells in the peripheral blood of cancer patients.
    Wolf AM; Wolf D; Steurer M; Gastl G; Gunsilius E; Grubeck-Loebenstein B
    Clin Cancer Res; 2003 Feb; 9(2):606-12. PubMed ID: 12576425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracorporeal photopheresis normalizes some lymphocyte subsets (including T regulatory cells) in chronic graft-versus-host-disease.
    Bladon J; Taylor P
    Ther Apher Dial; 2008 Aug; 12(4):311-8. PubMed ID: 18789119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating CD4+CD25+ T cells in rheumatic mitral stenosis.
    Yildiz A; Ozeke O; Aras D; Balci M; Deveci B; Ergun K; Topaloglu S; Dogan M; Ozcan F; Sokmen Y; Sasmaz A; Korkmaz S
    J Heart Valve Dis; 2007 Sep; 16(5):461-7. PubMed ID: 17944116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
    Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
    Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The severity of systemic lupus erythematosus negatively correlates with the increasing number of CD4+CD25(high)FoxP3+ regulatory T cells during repeated plasmapheresis treatments of patients.
    Baráth S; Soltész P; Kiss E; Aleksza M; Zeher M; Szegedi G; Sipka S
    Autoimmunity; 2007 Nov; 40(7):521-8. PubMed ID: 17966042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers.
    Ichihara F; Kono K; Takahashi A; Kawaida H; Sugai H; Fujii H
    Clin Cancer Res; 2003 Oct; 9(12):4404-8. PubMed ID: 14555512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Alterations of CD4+ CD25+ regulatory T cells in patients with idiopathic thrombocytopenic purpura].
    Ling Y; Cao XS; Yu ZQ; Luo GH; Bai X; Su J; Dai L; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2007 Mar; 28(3):184-8. PubMed ID: 17649712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid.
    van Amelsfort JM; Jacobs KM; Bijlsma JW; Lafeber FP; Taams LS
    Arthritis Rheum; 2004 Sep; 50(9):2775-85. PubMed ID: 15457445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased CD4CD25+FOXP3+ regulatory T Cells in cancer patients from conversion of CD4+CD25- T cells through tumor-derived factors.
    Mao C; Wang S; Jiang Q; Tong J; Ma J; Yang M; Xu X; Qiu G; Shao Q; Li L; Xu H
    Onkologie; 2008 May; 31(5):243-8. PubMed ID: 18497513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M; Piccirillo CA
    J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD4+CD25+FoxP3+ T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis.
    Kumar M; Putzki N; Limmroth V; Remus R; Lindemann M; Knop D; Mueller N; Hardt C; Kreuzfelder E; Grosse-Wilde H
    J Neuroimmunol; 2006 Nov; 180(1-2):178-84. PubMed ID: 17011048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased induction of allogeneic-specific cord blood CD4+CD25+ regulatory T (Treg) cells: a comparative study of naïve and antigenic-specific cord blood Treg cells.
    Chang CC; Satwani P; Oberfield N; Vlad G; Simpson LL; Cairo MS
    Exp Hematol; 2005 Dec; 33(12):1508-20. PubMed ID: 16338494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced Cd4+Cd25+ T cells in patients with idiopathic thrombocytopenic purpura.
    Sakakura M; Wada H; Tawara I; Nobori T; Sugiyama T; Sagawa N; Shiku H
    Thromb Res; 2007; 120(2):187-93. PubMed ID: 17067661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection.
    Stoop JN; van der Molen RG; Baan CC; van der Laan LJ; Kuipers EJ; Kusters JG; Janssen HL
    Hepatology; 2005 Apr; 41(4):771-8. PubMed ID: 15791617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.
    Shen LS; Wang J; Shen DF; Yuan XL; Dong P; Li MX; Xue J; Zhang FM; Ge HL; Xu D
    Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reciprocal CD4+ T-cell balance of effector CD62Llow CD4+ and CD62LhighCD25+ CD4+ regulatory T cells in small cell lung cancer reflects disease stage.
    Koyama K; Kagamu H; Miura S; Hiura T; Miyabayashi T; Itoh R; Kuriyama H; Tanaka H; Tanaka J; Yoshizawa H; Nakata K; Gejyo F
    Clin Cancer Res; 2008 Nov; 14(21):6770-9. PubMed ID: 18980970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD4+CD25+ regulatory T lymphocytes in tuberculous pleural effusion.
    Qin XJ; Shi HZ; Liang QL; Huang LY; Yang HB
    Chin Med J (Engl); 2008 Apr; 121(7):581-6. PubMed ID: 18466675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type 1 T regulatory cells and their relationship with CD4+CD25+ T regulatory cells.
    Roncarolo MG; Gregori S; Levings M
    Novartis Found Symp; 2003; 252():115-27; discussion 127-31, 203-10. PubMed ID: 14609215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychoneuroendocrine modulation of regulatory T lymphocyte system: in vivo and in vitro effects of the pineal immunomodulating hormone melatonin.
    Vigoré L; Messina G; Brivio F; Fumagalli L; Rovelli F; DI Fede G; Lissoni P
    In Vivo; 2010; 24(5):787-9. PubMed ID: 20952751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.